FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080967723> ?p ?o ?g. }

• W2080967723 endingPage "1042" @default.
• W2080967723 startingPage "1036" @default.
• W2080967723 abstract "This study was performed with the aim of discovering the characteristics and survival of patients with metastatic renal carcinoma who undergo immunotherapy with an Interleukin 2 based regimen. One hundred and eighty-one patients with metastatic renal carcinoma were referred to our institute from October 1987 until August 1991; 129 were treated with Interleukin 2 with or without Interferon alpha in three successive protocols. Fifty-two patients were not treated with immunotherapy due to the exclusion criteria of the protocols. Sixty-four patients with the same disease who had been referred to our institute before the initiation of this programme (1982, 1987) were also analysed as a control group. The main characteristics of the three different cohorts of patients were analysed and compared with univariate statistical tests; the median survival of the patients was calculated and compared. The referral rate increased from 13 a year to 45 a year while the IL2 trials were being conducted. Patients treated with cytokines have a median survival of 18 months after occurrence of metastases, compared to 6 and 8 months, respectively, in excluded patients and the control group. This parameter is of 15 months when the 181 patients, treated with cytokines or not, are considered. The survival of treated vs excluded patients is significantly different (P < 10(-6); so is the survival of the 181 patients recently included when compared to the historical group (P:10(-5). When the 181 recent patients are compared to the historical control group, a number of differences appear in their characteristics, which prevent us from drawing any conclusion about the role of immunotherapy in the improvement of survival observed. This study clearly evidences the selection of the patients receiving immunotherapy and the modification in referrals of a disease induced by a new available therapy. This emphasises the need for prospective studies in this setting." @default.
• W2080967723 created "2016-06-24" @default.
• W2080967723 creator A5007353311 @default.
• W2080967723 creator A5017427999 @default.
• W2080967723 creator A5018762519 @default.
• W2080967723 creator A5020353650 @default.
• W2080967723 creator A5020593337 @default.
• W2080967723 creator A5034534124 @default.
• W2080967723 creator A5037359039 @default.
• W2080967723 creator A5042202815 @default.
• W2080967723 creator A5042986036 @default.
• W2080967723 creator A5043594878 @default.
• W2080967723 creator A5047013029 @default.
• W2080967723 creator A5049127962 @default.
• W2080967723 creator A5062782526 @default.
• W2080967723 creator A5063162523 @default.
• W2080967723 creator A5087009217 @default.
• W2080967723 creator A5091091295 @default.
• W2080967723 date "1993-11-01" @default.
• W2080967723 modified "2023-10-17" @default.
• W2080967723 title "Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients" @default.
• W2080967723 cites W103243748 @default.
• W2080967723 cites W1483649639 @default.
• W2080967723 cites W1606300676 @default.
• W2080967723 cites W1968323919 @default.
• W2080967723 cites W1968981435 @default.
• W2080967723 cites W1970871013 @default.
• W2080967723 cites W1975568557 @default.
• W2080967723 cites W1976960199 @default.
• W2080967723 cites W1988282406 @default.
• W2080967723 cites W2013256551 @default.
• W2080967723 cites W2038252730 @default.
• W2080967723 cites W2042579365 @default.
• W2080967723 cites W2061189692 @default.
• W2080967723 cites W2150456060 @default.
• W2080967723 cites W2155221651 @default.
• W2080967723 cites W2159344485 @default.
• W2080967723 cites W2222964685 @default.
• W2080967723 cites W2295246435 @default.
• W2080967723 cites W2322553446 @default.
• W2080967723 cites W2326245275 @default.
• W2080967723 cites W2340256585 @default.
• W2080967723 cites W2409321133 @default.
• W2080967723 cites W2412037637 @default.
• W2080967723 cites W2419126207 @default.
• W2080967723 cites W4246629919 @default.
• W2080967723 doi "https://doi.org/10.1038/bjc.1993.476" @default.
• W2080967723 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1968726" @default.
• W2080967723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8217594" @default.
• W2080967723 hasPublicationYear "1993" @default.
• W2080967723 type Work @default.
• W2080967723 sameAs 2080967723 @default.
• W2080967723 citedByCount "16" @default.
• W2080967723 crossrefType "journal-article" @default.
• W2080967723 hasAuthorship W2080967723A5007353311 @default.
• W2080967723 hasAuthorship W2080967723A5017427999 @default.
• W2080967723 hasAuthorship W2080967723A5018762519 @default.
• W2080967723 hasAuthorship W2080967723A5020353650 @default.
• W2080967723 hasAuthorship W2080967723A5020593337 @default.
• W2080967723 hasAuthorship W2080967723A5034534124 @default.
• W2080967723 hasAuthorship W2080967723A5037359039 @default.
• W2080967723 hasAuthorship W2080967723A5042202815 @default.
• W2080967723 hasAuthorship W2080967723A5042986036 @default.
• W2080967723 hasAuthorship W2080967723A5043594878 @default.
• W2080967723 hasAuthorship W2080967723A5047013029 @default.
• W2080967723 hasAuthorship W2080967723A5049127962 @default.
• W2080967723 hasAuthorship W2080967723A5062782526 @default.
• W2080967723 hasAuthorship W2080967723A5063162523 @default.
• W2080967723 hasAuthorship W2080967723A5087009217 @default.
• W2080967723 hasAuthorship W2080967723A5091091295 @default.
• W2080967723 hasBestOaLocation W20809677232 @default.
• W2080967723 hasConcept C121608353 @default.
• W2080967723 hasConcept C126322002 @default.
• W2080967723 hasConcept C141071460 @default.
• W2080967723 hasConcept C143998085 @default.
• W2080967723 hasConcept C144301174 @default.
• W2080967723 hasConcept C2777472916 @default.
• W2080967723 hasConcept C2777546739 @default.
• W2080967723 hasConcept C2777701055 @default.
• W2080967723 hasConcept C2781413609 @default.
• W2080967723 hasConcept C38180746 @default.
• W2080967723 hasConcept C535046627 @default.
• W2080967723 hasConcept C71924100 @default.
• W2080967723 hasConcept C90924648 @default.
• W2080967723 hasConceptScore W2080967723C121608353 @default.
• W2080967723 hasConceptScore W2080967723C126322002 @default.
• W2080967723 hasConceptScore W2080967723C141071460 @default.
• W2080967723 hasConceptScore W2080967723C143998085 @default.
• W2080967723 hasConceptScore W2080967723C144301174 @default.
• W2080967723 hasConceptScore W2080967723C2777472916 @default.
• W2080967723 hasConceptScore W2080967723C2777546739 @default.
• W2080967723 hasConceptScore W2080967723C2777701055 @default.
• W2080967723 hasConceptScore W2080967723C2781413609 @default.
• W2080967723 hasConceptScore W2080967723C38180746 @default.
• W2080967723 hasConceptScore W2080967723C535046627 @default.
• W2080967723 hasConceptScore W2080967723C71924100 @default.
• W2080967723 hasConceptScore W2080967723C90924648 @default.
• W2080967723 hasIssue "5" @default.

• next